product summary
request information :
company name :
LifeSpan Biosciences
product type :
antibody
product name :
Anti-HTRA2 / OMI Antibody (clone EPR22) LS-C105496
catalog :
LS-C105496
clonality :
monoclonal
host :
rabbit
reactivity :
human
application :
immunocytochemistry, flow cytometry, immunoprecipitation, western blot, immunohistochemistry - paraffin section
product information
?AntibodyID :
107374
AntibodyName :
LS-C105496
TargetSpecies :
Human
Host Species :
Rabbit
Product Name :
Anti-HTRA2 / OMI Antibody (clone EPR22) LS-C105496
ClonalityDesc :
Monoclonal
CloneName :
EPR22
PresentationDesc :
Tris-Glycine-NaCl or PBS, pH 7.2-7.4, 40-50% Glycerol, 0.01% sodium azide, 0.05% BSA
ImmunogenType :
Synthetic peptide
ImmunogenDesc :
A synthetic peptide corresponding to residues of human HtrA2 was used as an immunogen.
PurificationDesc :
Tissue culture supernatant
RecommendedStorageDesc :
Store at -20°C.
IsotypeName :
IgG
Gene :
HTRA2 / OMI
StandardGeneSymbol :
HTRA2
gene family :
Protease
Subfamily :
Serine S1C
Reactivity :
Human, Mouse, Rat
Usage :
Flo (1:70), ICC (1:250 - 1:500), IHC-P (1:100 - 1:250), IP (1:10), WB (1:500 - 1:5000)
Synonyms :
HTRA2, HtrA-like serine protease, OMI, PARK13, Protease, serine, 25, PRSS25, Serine protease 25, HtrA serine peptidase 2, Serine proteinase OMI
company information
LifeSpan Biosciences
2401 Fourth Avenue, Suite 900
Seattle, WA 98121
antibodies@lsbio.com
www.lsbio.com
1-206-464-1554
headquarters: USA
Since 1995, LifeSpan has been the industry leader in molecular pathology, specializing in the localization of proteins in normal and diseased tissues, both human and non-human. We offer more than 74,000 antibodies, custom designed immunohistochemistry (IHC) studies, immediately available human tissue IHC profiles for more than 500 proteins, and histology and pathology services. Our bank of 2 million specimens is available to support our customers' contract research studies and contains frozen and formalin-fixed (FFPE) normal and diseased tissues. Our contract services are comprehensive; they include study design, antibody sourcing and characterization, tissue sourcing and validation, immunolabeling, trouble shooting, and interpretation of the results by a LifeSpan pathologist.